A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

Clinical trial NCT07272629 · COMPLETED

Trial details

NCT number: NCT07272629
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiac Repolarization Healthy Volunteers

Start date: 2025-12-04
Primary completion: 2026-05-28
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.